Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.

All News

Applied UV and Lootah Batta Water and Environment Sign Exclusive Distribution Agreement for Airocide(R) Air Purification Systems for the United Arab Emirates
BiotechnologyCompany Update

Applied UV and Lootah Batta Water and Environment Sign Exclusive Distribution Agreement for Airocide(R) Air Purification Systems for the United Arab Emirates

July 19, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / July 19, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of an exclusive distribution agreement with Lootah Batta Water...

Read more
EV Biologics NFT Dividend Update
BiotechnologyDividends

EV Biologics NFT Dividend Update

July 19, 2021 8:00 AM

NASHVILLE, TN / ACCESSWIRE / July 19, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend.On July 14, 2021 the Company announced a dividend of 1 NFT for every 100 shares of YECO common stock. The NFTs will be distributed via a special dividend to YECO's shareholders of record on July 30, 2021. Shareholders possessing less than 100 shares will not be eligible for this special dividend.MS Token is currently...

Read more
Black Bird Biotech Announces MiteXstream Summer Field Testing on Mite-Plagued Vegetable Crops in Israel by International Agri-Chem Company
BiotechnologyCompany Update

Black Bird Biotech Announces MiteXstream Summer Field Testing on Mite-Plagued Vegetable Crops in Israel by International Agri-Chem Company

July 19, 2021 7:30 AM

FLOWER MOUND, TX / ACCESSWIRE / July 19, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that an international agri-chemical company will begin field testing MiteXstream in Israel later this summer, when the rise of mite populations occurs, with testing completion expected in early October. The testing is slated to be conducted on eggplant and cucumber crops, vegetables...

Read more
Black Bird Biotech (BBBT) President to Appear on Newsmax TV’s New to the Street, Sunday, July 18, 2021, 10-11 AM ET
BiotechnologyCompany Update

Black Bird Biotech (BBBT) President to Appear on Newsmax TV’s New to the Street, Sunday, July 18, 2021, 10-11 AM ET

July 17, 2021 11:00 AM

FLOWER MOUND, TX / ACCESSWIRE / July 17, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, confirmed that its President, Fabian Deneault, will appear on FMW Media's nationally syndicated program, New to the Street, on Newsmax TV tomorrow, Sunday, July 18, 2021, from 10-11 am Eastern Time.For news and updates, shareholders, prospective investors and prospective business partners are...

Read more
Thermic Science Prepares to File the New Rule 15c2-11 Amendments Ahead of Schedule, the September 2021 Deadline for Required Financials & Filings Will Bring the Company Current and in Compliance With the OTC Market Reporting Changes
BiotechnologyExchange Listing Upgrade

Thermic Science Prepares to File the New Rule 15c2-11 Amendments Ahead of Schedule, the September 2021 Deadline for Required Financials & Filings Will Bring the Company Current and in Compliance With the OTC Market Reporting Changes

July 16, 2021 3:10 PM

NASHVILLE, TN / ACCESSWIRE / July 16, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is pleased to announce that the company has completed its required compliance financials and reporting records to bring the company current and filed ahead of schedule for the September 2021 deadline for the New Rule 15c2-11 Amendments...

Read more
Applied UV, Inc. Announces Closing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock
BiotechnologyRegulatory

Applied UV, Inc. Announces Closing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock

July 16, 2021 12:15 PM

MOUNT VERNON, NY / ACCESSWIRE / July 16, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the closing of its underwritten registered public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock, with liquidation...

Read more
Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer
BiotechnologyManagement Changes

Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer

July 16, 2021 7:00 AM

Veteran Executive Brings 30 Years of Financial and Operational Leadership ExperienceAUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced the hiring of Jeffrey G. Black as Chief Financial Officer. Mr. Black has served as Chief Financial Officer for a variety of publicly-traded companies in...

Read more
Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council
BiotechnologyCompany Update

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council

July 15, 2021 7:05 AM

VIRAL-MC21-1 Demonstrates Stability of DehydraTECH™-Enabled Antiviral DrugsKELOWNA, BC / ACCESSWIRE / July 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce results from its antiviral drug molecular characterization study VIRAL-MC21-1 recently completed by Canada's premier federally funded research organization, the National...

Read more
Viewpoint Molecular Targeting(R) Appoints Amos Hedt as Chief Business Strategy Officer
BiotechnologyManagement Changes

Viewpoint Molecular Targeting(R) Appoints Amos Hedt as Chief Business Strategy Officer

July 14, 2021 10:00 AM

Well-established research professional with expertise in early-stage pharmaceutical and biotechnology drug developmentCompany driving advancement of proprietary image-guided alpha-particle radiotherapies designed to optimize treatment, improve efficacy, and minimize the toxicity associated with many other cancer drugsCORALVILLE, IA / ACCESSWIRE / July 14, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a...

Read more
Applied UV's EU Distributor, Abiotec of France, Announces Airocide(R) Installations in Palace of Versailles to Protect Staff and Art
BiotechnologyCompany Update

Applied UV's EU Distributor, Abiotec of France, Announces Airocide(R) Installations in Palace of Versailles to Protect Staff and Art

July 14, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / July 14, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its European distributor, Abiotec of France, has installed Airocide® units...

Read more
EV Biologics Announces NFT Dividend
BiotechnologyDividends

EV Biologics Announces NFT Dividend

July 14, 2021 8:00 AM

CHEYENNE, WY / ACCESSWIRE / July 14, 2021 / EV Biologics Corp, OTC PINK:YECO, today announced that it will distribute a dividend of one (1) Non-Fungible Token (NFT) for every 100 shares of YECO common stock held on the record date. Shareholders possessing less than 100 shares will not be eligible for this special dividend.The NFTs will be given via a dividend to YECO's shareholders of record on July 30, 2021.CEO Daniel Mckinney said, 'This is...

Read more
Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D.
BiotechnologyCompany Update

Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D.

July 13, 2021 9:30 AM

World leader in the study of iron mediated cell death (IMCD)/ferroptosis, a novel cell death pathway used by cancer cells especially in drug resistant tumorsBRIDGEWATER, NJ / ACCESSWIRE / July 13, 2021 / Hillstream BioPharma, Inc. ("Hillstream", the "Company") today announced the expansion of the Scientific Advisory Board (SAB) with the addition of Scott J. Dixon, Ph.D., Associate Professor, Biology, Stanford University and Faculty Fellow of...

Read more
Pressure BioSciences UST-Enabled Nanoemulsions Soar Past One Year Stability Goal; Results Open Explosive Growth Potential for Water-Soluble CBD-Infused Beverages Worldwide
BiotechnologyCompany Update

Pressure BioSciences UST-Enabled Nanoemulsions Soar Past One Year Stability Goal; Results Open Explosive Growth Potential for Water-Soluble CBD-Infused Beverages Worldwide

July 13, 2021 8:57 AM

UST Nanoemulsions of CBD Deliver High Water-Solubility and Over One Year Storage Stability with No Degradation; UST Platform Primed to Revolutionize Food & Beverage, Biotherapeutic, Nutraceutical, and Agrochem ProductsSOUTH EASTON, MA / ACCESSWIRE / July 13, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and innovative...

Read more
Applied UV, Inc. Announces Pricing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock
BiotechnologyFinancing

Applied UV, Inc. Announces Pricing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock

July 13, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / July 13, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its underwritten registered public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock, with liquidation...

Read more
ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress
BiotechnologyProduct Announcements

ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress

July 13, 2021 8:30 AM

SAN CLEMENTE, CA / ACCESSWIRE / July 13, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the launch of ReShape Marketplace ™ as an extension of reshape care ™, the company's reimbursed telehealth service for weight loss across any physician prescribed therapy. ReShape Marketplace provides consumers with a collection of creative,...

Read more
Edesa Biotech Extends Dermatitis Study to Canada
BiotechnologyCompany Update

Edesa Biotech Extends Dermatitis Study to Canada

July 13, 2021 8:10 AM

TORONTO, ON / ACCESSWIRE / July 13, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that the company has expanded patient enrollment to Canada for the final part of a Phase 2b study evaluating its EB01 drug candidate as a monotherapy for chronic Allergic Contact Dermatitis (Eczema), or ACD. The first part of the ACD study was conducted in...

Read more
Nascent Biotech and Manhattan BioSolutions Announce Promising Prelim/Preclinical Results in BCG-Based COVID-19 Vaccine Research Collaboration
BiotechnologyCompany Update

Nascent Biotech and Manhattan BioSolutions Announce Promising Prelim/Preclinical Results in BCG-Based COVID-19 Vaccine Research Collaboration

July 13, 2021 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / July 13, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a biotechnology company pioneering innovative medicines to overcome difficult-to-treat cancers and viral infections, and its collaboration partner, Manhattan BioSolutions (together, the "Partners"), are pleased to announce promising new preliminary preclinical results for the COVID-19 vaccine candidate now progressing...

Read more
Lexaria Receives Patent Protection in Japan
BiotechnologyCompany Update

Lexaria Receives Patent Protection in Japan

July 13, 2021 7:05 AM

New patent granted in Japan adds to existing patents in the EU, the U.S., India and AustraliaKELOWNA, BC / ACCESSWIRE / July 13, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces an additional expansion of its intellectual property portfolio with its first-ever patent granted in Japan.The patent is titled "Stable ready-to-drink beverage compositions...

Read more
Applied UV to Present at the Ladenburg Thalmann Virtual Healthcare Conference
BiotechnologyConferences

Applied UV to Present at the Ladenburg Thalmann Virtual Healthcare Conference

July 9, 2021 9:00 AM

MOUNT VERNON, NY / ACCESSWIRE / July 9, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced the Company's management team will participate in the Ladenburg Thalmann Virtual...

Read more
Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference
BiotechnologyConferences

Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference

July 8, 2021 9:05 AM

Live webcast on Tuesday, July 13th at 1:00 PM ETIRVINE, CA / ACCESSWIRE / July 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical devices that restore cardiac and vascular health, today announced that Robert Berman, CEO of Hancock Jaffe will present at the Ladenburg Thalmann 2021 Healthcare Conference on Tuesday, July 13, 2021 at 1:00 PM ET.In addition to the presentation,...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?